Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Boschwitz, Theresa Zhang, Felix Dawson

Personal Genome Diagnostics named Jeffrey Boschwitz its chief operating officer, Theresa Zhang its VP of research services, and Felix Dawson to its board. Boschwitz was formerly executive VP of operations and corporate development at Plus Diagnostics. Prior to that, he was VP of North American sales and marketing at Orchid Cellmark and has held positions at Quest Diagnostics and Booz Allen Hamilton. 

Zhang joins PGDx from Merck Research Laboratories where she held various positions responsible for identification of predictive biomarkers and clinical implementation for oncology compounds. Dawson is a founding member of investment firm Wilkes Lane Capital. He previously was at Constellation Energy, now called Exelon, and at Goldman Sachs. 

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.